Daxor Corporation (DXR) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
DXR Revenue Growth
DXR Revenue Analysis (2013–2024)
As of May 9, 2026, Daxor Corporation (DXR) generated trailing twelve-month (TTM) revenue of $867,859, reflecting significant decline in growth of -74.4% year-over-year. The most recent quarter (Q2 2025) recorded $18,348 in revenue, down 97.4% sequentially.
Looking at the longer-term picture, DXR's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $34.6 million in 2023.
When compared to Healthcare sector peers including TFX (-6.6% YoY), HOLX (+2.2% YoY), and BAX (+5.1% YoY), DXR has underperformed the peer group in terms of revenue growth. Compare DXR vs TFX →
DXR Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| DXRCurrent | $867,859 | -74.4% | - | 29.2% | |
 TFX | $2.0B | -6.6% | -4.7% | 12.8% | |
 HOLX | $4.1B | +2.2% | +1.7% | 17.4% | |
 BAX | $11.2B | +5.1% | -0.7% | -2.7% | |
 BDX | $21.8B | +2.4% | +6.3% | 11.8% | |
 ISRG | $10.1B | +21.4% | +18.2% | 29.3% |
DXR Historical Revenue Data (2013–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $2.1M | -93.8% | $2.1M | 100.0% | $621K | 29.2% |
| 2023 | $34.6M | +9889.0% | $34.4M | 99.5% | $330K | 1.0% |
| 2022 | $-353,357 | +86.5% | $-1,440,430 | 407.6% | $5.3M | -1485.9% |
| 2021 | $-2,615,172 | +6.8% | $-3,616,700 | 138.3% | $4.7M | -181.6% |
| 2020 | $-2,806,340 | -2340.5% | $-3,492,756 | 124.5% | $-1,730,671 | 61.7% |
| 2019 | $-114,992 | +87.5% | $-482,159 | 419.3% | $-495,697 | 431.1% |
| 2018 | $-918,449 | +9.2% | $-1,186,927 | 129.2% | $-1,097,072 | 119.4% |
| 2017 | $-1,011,589 | -155.1% | $-1,211,672 | 119.8% | $-1,142,302 | 112.9% |
| 2016 | $1.8M | +124.7% | $1.6M | 84.9% | $1.5M | 80.0% |
| 2015 | $-7,443,855 | -83.6% | $-7,758,709 | 104.2% | $-7,880,675 | 105.9% |
See DXR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs DXR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare DXR vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonDXR — Frequently Asked Questions
Quick answers to the most common questions about buying DXR stock.
Is DXR's revenue growth accelerating or slowing?
DXR revenue declined -74.4% year-over-year, contrasting with the 5-year CAGR of N/A. TTM revenue fell to $867859.00. This reverses the prior growth trend.
What is DXR's long-term revenue growth rate?
Daxor Corporation's 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of -74.4% is below this long-term average.
How is DXR's revenue distributed by segment?
DXR reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.